BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 31097021)

  • 1. Multicellular gene network analysis identifies a macrophage-related gene signature predictive of therapeutic response and prognosis of gliomas.
    Sun X; Liu X; Xia M; Shao Y; Zhang XD
    J Transl Med; 2019 May; 17(1):159. PubMed ID: 31097021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-cell transcriptome-based multilayer network biomarker for predicting prognosis and therapeutic response of gliomas.
    Zhang J; Guan M; Wang Q; Zhang J; Zhou T; Sun X
    Brief Bioinform; 2020 May; 21(3):1080-1097. PubMed ID: 31329830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and validation of a risk signature based on extracellular matrix-related genes in gliomas.
    Liu J; Li G
    Medicine (Baltimore); 2021 Apr; 100(16):e25603. PubMed ID: 33879726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma.
    Maimaiti A; Wang X; Pei Y; Nuermaimaiti N; Tuersunniyazi A; Abula Y; Feng Z; Jiang L; Shi X; Kasimu M
    Aging (Albany NY); 2021 Jun; 13(11):15164-15192. PubMed ID: 34081618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ferroptosis-related gene signature correlates with the tumor immune features and predicts the prognosis of glioma patients.
    Hu Y; Tu Z; Lei K; Huang K; Zhu X
    Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34726238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of an epithelial-mesenchymal transition related long non-coding RNA (LncRNA) signature in Glioma.
    Tao C; Luo H; Chen L; Li J; Zhu X; Huang K
    Bioengineered; 2021 Dec; 12(1):4016-4031. PubMed ID: 34288803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive profiling identifies a novel signature with robust predictive value and reveals the potential drug resistance mechanism in glioma.
    Zeng F; Wang K; Liu X; Zhao Z
    Cell Commun Signal; 2020 Jan; 18(1):2. PubMed ID: 31907037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas.
    Zhang H; Li X; Li Y; Chen B; Zong Z; Shen L
    Front Immunol; 2020; 11():603341. PubMed ID: 33363544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioinformatic Profiling Identifies a Fatty Acid Metabolism-Related Gene Risk Signature for Malignancy, Prognosis, and Immune Phenotype of Glioma.
    Qi Y; Chen D; Lu Q; Yao Y; Ji C
    Dis Markers; 2019; 2019():3917040. PubMed ID: 31885736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An autophagic gene-based signature to predict the survival of patients with low-grade gliomas.
    Chen J; Li Y; Han X; Pan Y; Qian X
    Cancer Med; 2021 Mar; 10(5):1848-1859. PubMed ID: 33591634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicellular biomarkers of drug resistance as promising targets for glioma precision medicine and predictors of patient survival.
    Lu Y; Shao Y
    Cancer Drug Resist; 2022; 5(2):511-533. PubMed ID: 35800363
    [No Abstract]   [Full Text] [Related]  

  • 12. Prognostic value of a nine-gene signature in glioma patients based on tumor-associated macrophages expression profiling.
    Shan X; Zhang C; Wang Z; Wang K; Wang J; Qiu X; Jiang T; Yang P
    Clin Immunol; 2020 Jul; 216():108430. PubMed ID: 32325251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel pyroptosis-related gene signature predicts the prognosis of glioma through immune infiltration.
    Zhang M; Cheng Y; Xue Z; Sun Q; Zhang J
    BMC Cancer; 2021 Dec; 21(1):1311. PubMed ID: 34876094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of an Immune-Related Gene Signature for Risk Stratification for Patients with Glioma.
    He J; Zeng C; Long Y
    Comput Math Methods Med; 2021; 2021():2191709. PubMed ID: 34497663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single cell RNA sequencing reveals differentiation related genes with drawing implications in predicting prognosis and immunotherapy response in gliomas.
    Zhou Z; Wei J; Yang Z; Bao Y; Jiang W; Lu B; Wang W; Li L
    Sci Rep; 2022 Feb; 12(1):1872. PubMed ID: 35115572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N6-methyladenine-related genes affect biological behavior and the prognosis of glioma.
    Qu S; Chen Z; Liu B; Liu J; Wang H
    Cancer Med; 2021 Jan; 10(1):98-108. PubMed ID: 33264518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and validation of a five-lncRNA prognostic signature related to Glioma using bioinformatics analysis.
    Zhang C; Liu H; Xu P; Tan Y; Xu Y; Wang L; Liu B; Chen Q; Tian D
    BMC Cancer; 2021 Mar; 21(1):251. PubMed ID: 33750353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell aging related genes can be used to characterize clinical prognoses and further stratify diffuse gliomas.
    Yang Y; Chen X; Sun J; Chen S; Yang C; Ma Q; Yang J
    Sci Rep; 2021 Sep; 11(1):19493. PubMed ID: 34593910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aggrephagy-related gene signature correlates with survival and tumor-associated macrophages in glioma: Insights from single-cell and bulk RNA sequencing.
    Zhang X; Tan J; Zhang X; Pandey K; Zhong Y; Wu G; He K
    Math Biosci Eng; 2024 Jan; 21(2):2407-2431. PubMed ID: 38454689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploration of the radiosensitivity-related prognostic risk signature in patients with glioma: evidence from microarray data.
    Zhang X; Ren Q; Li Z; Xia X; Zhang W; Qin Y; Wu D; Ren C
    J Transl Med; 2023 Sep; 21(1):618. PubMed ID: 37700319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.